Shares of Sun Pharmaceutical slipped over 2 per cent Thursday, a day after markets regulator Sebi said it was examining the whistleblower complaint against the company.
The stock dropped 2.12 per cent to settle at Rs 422.15 on the BSE. During the trading session, the scrip touched a low of Rs 418, a decline of 3.08 per cent.
On the NSE, the stock fell 2.19 per cent to Rs 422 from the previous close. It had touched a low of Rs 418, down 3.11 per cent, during the trading session.
In terms of equity volume, over 13 lakh shares were traded on the BSE, while over 1.6 crore units changed hands on the NSE.
When asked about the whistleblower complaint against Sun Pharma, Sebi Chairman Ajay Tyagi on Wednesday said, "There is a whistleblower complaint which we are examining. I have nothing more to add."
Disclaimer: No Business Standard Journalist was involved in creation of this content